ArticleCancers2023

Sodium-Glucose Cotransporter-2 Inhibitor versus Beta-Blocker Use for Hepatocellular Carcinoma Risk among People with Hepatitis B or C Virus Infection and Diabetes Mellitus.

Wei-Syun Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.